Login / Signup

Update on Neuropathies in Inborn Errors of Metabolism.

Renata PająkEwelina MendelaNatalia BędkowskaJustyna Paprocka
Published in: Brain sciences (2021)
Neuropathies are relatively common in inborn errors of metabolism (IEMs); however, due to the early onset and severe, progressive course of many IEMs, they have not been very well researched yet. This article aims to review and compare neuropathies in inborn errors of metabolism, mostly with childhood and juvenile onset. Some of these diseases are treatable if diagnosed early and in many cases, the therapy can not only slow down disease progression, but can also reverse the changes already made by the condition.
Keyphrases
  • early onset
  • late onset
  • patient safety
  • adverse drug
  • multiple sclerosis
  • stem cells
  • emergency department
  • mesenchymal stem cells
  • quality improvement
  • young adults